Post-earnings recap
Reported
Thu, Nov 7, 2024
EPS actual
$1.61
EPS est.
$1.54
EPS surprise
+4.21%
1-day move
+0.61%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported a strong earnings per share, beating expectations slightly. The stock reacted positively, increasing by 0.61%. However, without revenue figures or management commentary, it's difficult to gauge the overall performance and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.61 | N/A | +4.21% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.